Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Jun 27, 2023; 15(6): 1125-1137
Published online Jun 27, 2023. doi: 10.4240/wjgs.v15.i6.1125
Table 2 Pathological characteristics of patients with gastric cancer according albumin-bilirubin groups, n (%)
Variables
Low-ALBI group (< -2.82), n = 211
High-ALBI group (≥ -2.82), n = 150
P value
Lauren type0.367
    Intestinal124 (58.8)81 (54.0)
    Diffuse/mixed87 (41.2)69 (46.0)
Histological differentiation0.993
    Well/moderately differentiated107 (59.7)76 (50.7)
    Poorly differentiated104 (49.3)74 (49.3)
Lymphatic invasion0.132
    No121 (57.3)74 (49.3)
    Yes90 (42.7)76 (50.7)
Venous invasion0.196
    No150 (71.1)97 (64.7)
    Yes61 (28.9)53 (35.3)
Perineural invasion0.743
    No112 (53.1)77 (51.3)
    Yes99 (46.9)73 (48.7)
T status0.105
    pT1/T291 (43.1)52 (34.7)
    pT3/T4120 (56.9)98 (65.3)
No of dissected lymph nodes0.543
    mean (SD)40.9 (17.7)39.8 (17.2)
pN status0.239
    pN099 (46.9)61 (40.7)
    pN+112 (53.1)89 (59.3)
pTNM0.222
    I/II122 (57.8)77 (51.3)
    III89 (42.2)73 (48.7)